Precision Detection
for CAR-T Monitoring
Developed in Heidelberg, Germany
Precision-Engineered for Cell Therapy Research
BlueRay Precision develops proprietary detection reagents and standardized reference materials for CAR T cell flow cytometry. Built on years of scientific development in Heidelberg, Germany, our SCOPE Technology delivers the accuracy and consistency that cell therapy research demands.
Enabling precise quantification of CAR receptor density and standardized measurement of Accessible CAR Molecules (ACM) per cell.
Precision & Accuracy
Rigorously validated reagents with low background and high specificity
Proprietary Development
In-house developed reagents with protected intellectual property
Scientific Rigor
Years of research and optimization ensuring reproducible performance
Standardization Focus
Enabling comparable results across laboratories worldwide
The SCOPE Technology
A comprehensive approach to standardized CAR T cell detection
SCOPE Detection Reagents
Antigen-based CAR detection reagents optimized for stable, reproducible staining with low background and robust specificity.
Learn more →SCOPE Reference Cell Mimics
Standardized cell controls for instrument checks and inter-lab normalization, ensuring consistent calibration.
Learn more →SCOPE Certification
Coming Soon: Proficiency-style program enabling routine external quality assessment and consistent reporting.
Join early access →Standardization Workflow
Four simple steps to consistent, comparable results
Verify with SCOPE Reference Materials
Run standardized control materials alongside samples to validate instrument performance and baseline settings.
Normalize Instrument Settings
Adjust gating strategy and instrument parameters based on standardized controls.
Stain with SCOPE Detection Reagents
Apply calibrated detection reagents to quantify CAR surface expression.
Generate Quantitative & Comparable Data
Produce standardized datasets with reproducible CAR receptor density measurements and meaningful cross-laboratory comparability.
Addressing Industry Challenges
Current CAR T cell detection faces critical challenges that impact research reproducibility and data comparability.
High Cost Per Test
Expensive proprietary reagents limit accessibility for routine monitoring and research applications.
Batch Variability
Inconsistent performance between batches and platforms undermines reproducibility.
Limited Standardization
Lack of global standards prevents meaningful data comparison across laboratories.
No Quantitative Calibration
Lack of quantitative receptor density measurement and absence of globally standardized CAR molecule calibration.
Technical Advantages
Low Background & High Specificity
Designed for robust performance with minimal non-specific binding
Manufacturing Reproducibility
Optimized production processes ensure batch-to-batch consistency
Universal Compatibility
Workflow mindset compatible with standard flow cytometry platforms